Growth Metrics

Pfizer (PFE) Cash & Equivalents (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 49.12%
Dec 31, 2025 -14.97%
Sep 28, 2025 -18.01%
Jun 29, 2025 14.55%
Mar 30, 2025 37.10%
Dec 31, 2024 -4.49%
Sep 29, 2024 3.80%
Jun 30, 2024 46.31%
Mar 31, 2024 -74.80%
Dec 31, 2023 -9.37%
Oct 1, 2023 19.60%
Jul 2, 2023 21.51%
Apr 2, 2023 420.67%
Dec 31, 2022 -67.95%
Oct 2, 2022 -27.08%
Jul 3, 2022 -27.94%
Apr 3, 2022 27.06%
Dec 31, 2021 -1.12%
Oct 3, 2021 -17.12%
Jul 4, 2021 34.16%
Apr 4, 2021 -1.01%
Dec 31, 2020 12.54%
Sep 27, 2020 -11.88%
Jun 28, 2020 -16.27%
Mar 29, 2020 91.88%
Dec 31, 2019 -59.75%
Sep 29, 2019 56.11%
Jun 30, 2019 -7.90%
Mar 31, 2019 70.06%
Dec 31, 2018 -68.00%
Sep 30, 2018 31.62%
Jul 1, 2018 11.92%
Apr 1, 2018 68.83%
Dec 31, 2017 -49.93%
Oct 1, 2017 7.40%
Jul 2, 2017 -35.58%
Apr 2, 2017 54.95%
Dec 31, 2016 27.32%
Oct 2, 2016 -38.61%
Jul 3, 2016 33.19%
Apr 3, 2016 -30.91%
Dec 31, 2015 19.62%
Sep 27, 2015 -15.56%
Jun 28, 2015 3.00%
Mar 29, 2015 6.58%
Dec 31, 2014 37.18%
Sep 28, 2014 -28.45%
Jun 29, 2014 19.01%
Mar 30, 2014 31.10%
Dec 31, 2013 6.38%
Sep 29, 2013 -15.76%
Jun 30, 2013 28.75%
Mar 31, 2013 -81.23%
Dec 31, 2012 123.72%
Sep 30, 2012 48.66%
Jul 1, 2012 3.31%
Apr 1, 2012 -7.79%
Dec 31, 2011 -14.14%
Oct 2, 2011 19.70%
Jul 3, 2011 324.11%
Apr 3, 2011 -57.93%
Dec 31, 2010 -20.27%
Oct 3, 2010 15.93%
Jul 4, 2010 6.71%
Apr 4, 2010 -11.07%
Dec 31, 2009 -53.28%
Sep 27, 2009 88.68%
Jun 28, 2009 79.95%